Skip to Content
Merck
  • Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.

Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.

Journal of medicinal chemistry (2012-09-08)
Alexander N Wein, Brian N Williams, Shihui Liu, Boris Ermolinsky, Daniele Provenzano, Ruben Abagyan, Andrew Orry, Stephen H Leppla, Michael Peredelchuk
ABSTRACT

Protective antigen (PA), lethal factor, and edema factor, the protein toxins of Bacillus anthracis , are among its most important virulence factors and play a key role in infection. We performed a virtual ligand screen of a library of 10000 members to identify compounds predicted to bind to PA and prevent its oligomerization. Four of these compounds slowed PA association in a FRET-based oligomerization assay, and two of those protected cells from intoxication at concentrations of 1-10 μM. Exploration of the protective mechanism by Western blot showed decreased SDS-resistant PA oligomer on cells and, surprisingly, decreased amounts of activated PA. In vitro assays showed that one of the inhibitors blocked furin-mediated cleavage of PA, apparently through its binding to the PA substrate. Thus, we have identified inhibitors that can independently block both PA's cleavage by furin and its subsequent oligomerization. Lead optimization on these two backbones may yield compounds with high activity and specificity for the anthrax toxins.